The Research and Development team at Day Zero Diagnostics is dedicated to innovating and enhancing next-generation sequencing techniques for infectious disease diagnostics. This team conducts advanced research in molecular biology, computational analysis, and machine learning to develop and validate new diagnostic assays. By integrating cutting-edge technologies and interdisciplinary expertise, they aim to produce scalable, clinically actionable data that can transform patient care in infectious diseases.
View all